<p>Cells were treated with QD, PR9, chloroquine, PR9/QD, QD/chloroquine, PR9/QD/chloroquine, QInP alone and PR9/QInP complexes for 24 h. Significant differences at <i>P</i><0.05 (*) and <i>P</i><0.01 (**) are indicated. Data are presented as mean ± SD from three independent experiments.</p
<p>Chemomedulatory effects of test compounds on the cytotoxicity parameters of PTX against LS-174T c...
<p>L929 cells were cultured for 48 hrs in the absence or presence of decreasing concentrations of ve...
<p>Cells were treated with either vehicle (control) or 15 to 1200 µM of TUDCA for 24 hours. A, TUDCA...
<p>(A) Cellular uptake of PR9/QD complexes without or with inhibitors. Cells were treated with PBS a...
<p>The relative cell viability (%) related to control wells containing cell culture medium without n...
<p>(A) Influence of IR9-FITC, IR9 and IR9/QD complexes on A549 cell viability. Cells were treated wi...
<p>Cytotoxicity of PR-GO in terms of MTT, Resazurin and neutral red uptakeassays.</p
<p>Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and ...
<p>(A) Intracellular trafficking of PR9/QInP complexes. A549 cells were treated with PR9/QInP comple...
<p>A, The IC<sub>50</sub> values after drug exposure for 72 h are shown. B, The IT<sub>50</sub> valu...
<p><b>(A)</b> A549cisR cells treated overnight with cisplatin and chloroquine. Next day, cytosolic (...
<p>Cell viability was assessed by MTT assay after HL-60 cells were exposed to CYS9 with and without ...
<p>THP-1 cells were treated with the decreasing concentration (10–0.039 μM) of 1, 5, and 9, respecti...
<p>Cells were exposed to serial dilution of PTX (●), Chemosensetizer (▼) or their combination (○) fo...
<p>MDA-MB-231 cells were used as a model. <b>A</b>. Dose-dependence of CQ cytotoxicity was calculate...
<p>Chemomedulatory effects of test compounds on the cytotoxicity parameters of PTX against LS-174T c...
<p>L929 cells were cultured for 48 hrs in the absence or presence of decreasing concentrations of ve...
<p>Cells were treated with either vehicle (control) or 15 to 1200 µM of TUDCA for 24 hours. A, TUDCA...
<p>(A) Cellular uptake of PR9/QD complexes without or with inhibitors. Cells were treated with PBS a...
<p>The relative cell viability (%) related to control wells containing cell culture medium without n...
<p>(A) Influence of IR9-FITC, IR9 and IR9/QD complexes on A549 cell viability. Cells were treated wi...
<p>Cytotoxicity of PR-GO in terms of MTT, Resazurin and neutral red uptakeassays.</p
<p>Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and ...
<p>(A) Intracellular trafficking of PR9/QInP complexes. A549 cells were treated with PR9/QInP comple...
<p>A, The IC<sub>50</sub> values after drug exposure for 72 h are shown. B, The IT<sub>50</sub> valu...
<p><b>(A)</b> A549cisR cells treated overnight with cisplatin and chloroquine. Next day, cytosolic (...
<p>Cell viability was assessed by MTT assay after HL-60 cells were exposed to CYS9 with and without ...
<p>THP-1 cells were treated with the decreasing concentration (10–0.039 μM) of 1, 5, and 9, respecti...
<p>Cells were exposed to serial dilution of PTX (●), Chemosensetizer (▼) or their combination (○) fo...
<p>MDA-MB-231 cells were used as a model. <b>A</b>. Dose-dependence of CQ cytotoxicity was calculate...
<p>Chemomedulatory effects of test compounds on the cytotoxicity parameters of PTX against LS-174T c...
<p>L929 cells were cultured for 48 hrs in the absence or presence of decreasing concentrations of ve...
<p>Cells were treated with either vehicle (control) or 15 to 1200 µM of TUDCA for 24 hours. A, TUDCA...